Is Your Drug Launch Set Up to Avoid Commercialization Failure?
For market access leaders, launching a new product can be a high stakes challenge. With nearly two-thirds of drug...
Resources
Your Hub Program Can’t Succeed Without Both High-Tech and High-Touch Support
Nov 15, 2024 by CareMetx
In the fast-paced world of specialty drug access, you need both people and technology to give patients the ideal level...
Is Your Hub Underperforming in Reverification Season? Discover How CareMetx Leads the Way
Nov 13, 2024 by CareMetx
The annual reverification season demands flawless execution, but many well-known hub providers repeatedly fall short....
Here’s Why You Should Retain Allscripts (MDRX) Stock For Now
Nov 22, 2021 by CareMetx
Allscripts Healthcare Solutions, Inc. MDRX is well-poised for growth in the coming quarters, backed by its strategic...
A Conversation with Mark Hansan, CareMetx
Mar 8, 2020 by CareMetx
CareMetx was founded in 2011 by two longtime industry executives, Bob Dresing and Mark Hansan, who started in the...
Value-based agreements could disrupt how we pay for new therapies
Aug 4, 2019 by CareMetx
On Tuesday, the Senate Finance Committee will hold its second hearing in a series on drug pricing. Led by chairman...
CareMetx Offers Highest Patient Automation, Reach for Electronic Prescription Benefit Verification
Jan 9, 2025 by CareMetx
Bethesda, MD, January 7, 2025 – CareMetx, a leading technology-enabled hub services platform facilitating patient...
CareMetx Welcomes Scott Genone as Chief Product Officer
Nov 4, 2024 by CareMetx
Genone brings over 30 years of healthcare technology leadership, set to elevate product innovation and patient access....
CareMetx Receives US Patent for Automated Manufacturer Program Patient Enrollment Tool
Sep 25, 2024 by CareMetx
Bethesda, MD, September 24, 2024 – CareMetx, a leading technology-enabled hub services platform facilitating patient...
Case Study: CareMetx Facilitates Seamless Vaccine Access While Outperforming SLA Criteria
May 9, 2024 by CareMetx
This global biopharmaceutical company worked with CareMetx to improve patient access to two of its vaccines. CareMetx's...
CareMetx Leverages AI and Best Practices to Complete 450k+Annual Reverifications Accurately and Ahead of Schedule
May 3, 2024 by CareMetx
CareMetx employed AI and best practices to expedite over 450,000 annual reverifications (AR), ensuring patients receive...
Case Study: CareMetx leveraged specialized patient support services to help navigate the hurdles associated with biosimilar products.
Feb 16, 2024 by CareMetx
CareMetx leveraged specialized patient support services to help navigate the hurdles associated with biosimilar...